A soluble form of IL-13 receptor α1 promotes IgG2a and IgG2b production by murine germinal center B cells

被引:0
作者
Poudrier, J
Graber, P
Herren, S
Gretener, D
Elson, G
Berney, C
Gauchat, JF
Kosco-Vilbois, MH
机构
[1] Serono Pharmaceut Res Inst, Dept Immunol, CH-1228 Geneva, Switzerland
[2] Ctr Immunol Pierre Fabre, St Julien En Genevois, France
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A functional IL-13R involves at least two cell surface proteins, the IL-13R alpha 1 and IL-4R alpha. Using a soluble form of the murine IL-13R alpha 1 (sIL-13R), we reveal several novel features of this system. The sIL-13R promotes proliferation and augmentation of Ag-specific IgM, IgG2a, and IgG2b production by murine germinal center (GC)B cells in vitro. These effects were enhanced by CD40 signaling and were not inhibited by an anti-IL4R alpha mAb, a result suggesting other ligands. In GC cell cultures, sIL-13R also promoted IL-6 production, and interestingly, sIL-13R-induced IgG2a and IgG2b augmentation was absent in GC cells isolated from nd-deficient mice. Furthermore, the effects of the sIL-13R molecule were inhibited in the presence of an anti-IL-13 mAb, and preincubation of GC cells with IL-13 enhanced the sIL-13R-mediated effects. When sIL-13R was injected into mice, it served as an adjuvant-promoting production to varying degrees of IgM and IgG isotopes. We thus propose that IL-13R alpha 1 is a molecule involved in B cell differentiation, using a mechanism that may involve regulation of IL-6-responsive elements. Taken together, our data reveal previously unknown activities as well as suggest that the ligand for the sIL-13R might be a component of the IL-13R complex or a counterstructure yet to be defined.
引用
收藏
页码:1153 / 1161
页数:9
相关论文
共 59 条
[11]   HOW B-CELLS AND T-CELLS TALK TO EACH OTHER [J].
CLARK, EA ;
LEDBETTER, JA .
NATURE, 1994, 367 (6462) :425-428
[12]   INTERLEUKIN-13 IS A B-CELL STIMULATING FACTOR [J].
DEFRANCE, T ;
CARAYON, P ;
BILLIAN, G ;
GUILLEMOT, JC ;
MINTY, A ;
CAPUT, D ;
FERRARA, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (01) :135-143
[13]   INTERLEUKIN-13 STIMULATES INTERLEUKIN-6 PRODUCTION BY HUMAN KERATINOCYTES [J].
DEROCQ, JM ;
SEGUI, M ;
POINOTCHAZEL, C ;
MINTY, A ;
CAPUT, D ;
FERRARA, P ;
CASELLAS, P .
FEBS LETTERS, 1994, 343 (01) :32-36
[14]   IMMUNOREGULATORY PROPERTIES OF IL-13 - ITS POTENTIAL ROLE IN ATOPIC DISEASE [J].
DEVRIES, JE ;
ZURAWSKI, G .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1995, 106 (03) :175-179
[15]  
DiSanto E, 1997, J IMMUNOL, V159, P379
[16]  
DOHERTY TM, 1993, J IMMUNOL, V151, P7151
[17]  
Donaldson DD, 1998, J IMMUNOL, V161, P2317
[18]   Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: Involvement of STAT3 in anti-apoptosis [J].
Fukada, T ;
Hibi, M ;
Yamanaka, Y ;
TakahashiTezuka, M ;
Fujitani, Y ;
Yamaguchi, T ;
Nakajima, K ;
Hirano, T .
IMMUNITY, 1996, 5 (05) :449-460
[19]   A novel 4-kb interleukin-13 receptor alpha mRNA expressed in human B, T, and endothelial cells encoding an alternate type-II interleukin-4/interleukin-13 receptor [J].
Gauchat, JF ;
Schlagenhauf, E ;
Feng, NP ;
Moser, R ;
Yamage, M ;
Jeannin, P ;
Alouani, S ;
Elson, G ;
Notarangelo, LD ;
Wells, T ;
Eugster, HP ;
Bonnefoy, JY .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (04) :971-978
[20]  
Graber P, 1998, EUR J IMMUNOL, V28, P4286, DOI 10.1002/(SICI)1521-4141(199812)28:12<4286::AID-IMMU4286>3.0.CO